GeneOne Life Science Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.9%.

Top 20 shareholders own 16.36% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.02%	Young-Keun Park	7,202,613	₩14.8b	0%	no data
3.2%	The Vanguard Group, Inc.	2,557,270	₩5.2b	2.17%	no data
1.11%	Byung-Mun Cho	887,926	₩1.8b	17.2%	no data
1.11%	Jo Byeong Mun	887,926	₩1.8b	17.2%	no data
0.83%	Dimensional Fund Advisors LP	664,209	₩1.4b	29.5%	no data
0.23%	Mirae Asset Global Investments Co., Ltd.	185,759	₩380.8m	-0.24%	no data
0.17%	Je-Kyung Che	135,817	₩278.4m	79.1%	no data
0.16%	State Street Global Advisors, Inc.	129,878	₩266.2m	0.38%	no data
0.15%	BlackRock, Inc.	123,075	₩252.3m	-5.56%	no data
0.14%	Samsung Asset Management Company, Ltd.	109,983	₩225.5m	-0.32%	no data
0.11%	Seong-Ho Choi	86,414	₩177.2m	0%	no data
0.081%	Hui-Kon Park	64,500	₩132.2m	0%	no data
0.017%	Hanwha Asset Management Co. Ltd.	13,216	₩27.1m	0%	no data
0.01%	HDC Asset Management Co., Ltd.	8,181	₩16.8m	0%	0.04%
0.0056%	KB Asset Management Co., Ltd.	4,452	₩9.1m	0%	no data
0.00069%	NH-Amundi Asset Management	553	₩1.1m	0%	no data
0.00065%	Kyobo AXA Investment Managers Co., Ltd.	519	₩1.1m	0%	no data
0.0006%	Invesco Capital Management LLC	481	₩981.9k	0%	no data
0.00036%	BMO Asset Management Corp.	289	₩589.1k	0%	no data
0.00033%	Korea Investment Management Co., Ltd.	265	₩540.0k	-67.2%	no data